We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Warner Chilcott Prevails Vs. Teva In Sarafem Patent Suit

Law360 (August 6, 2004, 12:00 AM EDT) -- A federal district court has upheld the validity of a patent for Irish drug maker Warner Chilcott’s pre-menstrual dysphoric disorder treatment Sarafem, rejecting a challenge by Israeli generics maker Teva Pharmaceuticals.

In a 90-page decision, Chief Judge Sarah Barker of the U.S. District Court for the Southern District of Indiana found in favor of Lilly and Warner Chilcott, and upheld the validity of the Sarafem patent. As a result, injunctive relief is available to Warner Chilcott until the expiration of the patent in May 2008....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.